Mass tort litigation is often discussed in collective terms. Hundreds or even thousands of plaintiffs may allege that the same pharmaceutical product, medical device, chemical exposure, or consumer product caused similar injuries. Their claims may be coordinated for pretrial purposes, subjected to common discovery, or grouped within multidistrict litigation. Yet the scale of the litigation can obscure a fundamental principle: every plaintiff must ultimately establish that the defendant’s conduct or product caused that particular plaintiff’s injury.
That requirement distinguishes mass tort litigation from a conventional class action in an important way. Although plaintiffs may benefit from shared evidence concerning product design, corporate conduct, warnings, regulatory history, or general scientific questions, individual causation remains highly fact-specific. For mass tort attorneys in Southern California and elsewhere, establishing that connection can become one of the most demanding aspects of building a viable claim.
General Causation Is Only the Beginning
Causation in complex injury litigation is often divided into two related concepts: general causation and specific causation. General causation asks whether the product or exposure in question is capable of causing the type of injury alleged. Specific causation asks whether it actually caused the injury suffered by a particular plaintiff.
The distinction is significant. A scientific study might demonstrate an association between exposure to a chemical and an increased incidence of a particular disease. That evidence may support an argument that the chemical is capable of causing the condition, but it does not automatically establish what caused any individual patient’s diagnosis. Other medical conditions, environmental exposures, genetic factors, medications, occupational risks, or lifestyle considerations may need to be examined.
This is one reason expert evidence assumes such importance in mass tort cases. Epidemiologists, toxicologists, physicians, pathologists, engineers, and other specialists may be asked to evaluate different aspects of the causal chain. Their conclusions must often withstand challenges concerning methodology, reliability, relevance, and whether the underlying scientific evidence genuinely supports the opinions being offered.
The result is that a plaintiff may be participating in litigation where substantial evidence exists against a defendant at a general level while still facing significant questions about the strength of their own case.
Shared Litigation Does Not Mean Identical Claims
Procedural coordination can create efficiencies that would be difficult to achieve if thousands of cases proceeded entirely independently. Courts may oversee common discovery, resolve recurring legal disputes, consider challenges to expert testimony, and manage documents that apply across a large group of claims. These efficiencies are particularly valuable when litigation involves millions of pages of corporate records or extensive scientific evidence.
But coordination does not eliminate differences among plaintiffs.
One claimant may have used a product for several years, while another used it only briefly. One may have developed symptoms shortly after exposure, while another may not have been diagnosed until decades later. Some plaintiffs may have extensive medical documentation establishing product use, while others may have difficulty identifying precisely when, where, or how they were exposed.
These differences can affect both causation and damages. They may also determine whether a claim survives dispositive motions, whether it is considered suitable for settlement, and how a defendant evaluates its litigation risk.
Medical history can be especially important. Defense counsel frequently examines whether an injury has plausible alternative explanations. If a plaintiff alleges that a particular substance caused cancer, for example, the litigation may involve detailed scrutiny of family history, occupational exposure, smoking history, previous illnesses, medication use, age, and other known risk factors. The existence of another risk factor does not necessarily defeat a claim, but it may complicate the effort to prove causation to the required legal standard.
Exposure Evidence Can Be Just as Important as Medical Evidence
Before addressing whether an exposure caused an injury, a claimant often has to establish that the relevant exposure actually occurred. That issue can become surprisingly difficult in litigation involving events from many years earlier.
Pharmacy records may no longer exist. Employers may have closed. Product packaging may have been discarded decades ago. Medical records may identify a treatment without specifying the manufacturer. A claimant may remember using a product but have difficulty establishing the exact model, dosage, duration, or frequency.
Accordingly, attorneys may seek evidence from numerous sources. Prescription histories, medical notes, employment files, purchase records, insurance documents, photographs, witness statements, product serial numbers, and corporate distribution records can all become relevant. In some cases, evidence concerning where a claimant lived or worked may help reconstruct the likely circumstances of exposure.
The quality of this evidence matters because mass tort defendants have strong incentives to challenge weak product identification or uncertain exposure histories. A compelling body of scientific evidence concerning a product does relatively little for a plaintiff who cannot establish that they actually used or encountered it.
Timing can create another layer of complexity. Certain diseases have long latency periods, meaning substantial time may pass between exposure and diagnosis. In other cases, the chronology may raise doubts if symptoms appear too soon or too long after the alleged exposure to fit the accepted scientific mechanism. Developing an accurate timeline can therefore become a central part of causation analysis rather than a routine administrative exercise.
Bellwether Cases Highlight the Importance of Individual Facts
Bellwether trials provide a useful illustration of why individual causation remains so important. In large multidistrict proceedings, selected cases may proceed to trial before the remainder of the litigation. These cases can provide both sides with information about how juries respond to liability arguments, expert evidence, causation theories, and claimed damages.
The broader litigation may share substantial common evidence, but bellwether outcomes can vary dramatically because the plaintiffs themselves have different histories.
A claimant with well-documented exposure, a clear diagnosis, persuasive treating physicians, and relatively few competing risk factors may present very differently from a claimant whose exposure history is uncertain or whose medical circumstances provide several plausible alternative explanations. Even when the alleged wrongdoing by the defendant is identical, the strength of the causal connection may not be.
This helps explain why one bellwether verdict should rarely be interpreted as determining the value or likely outcome of every remaining claim. Favorable or unfavorable verdicts can influence negotiations, but mass tort inventories generally contain cases of varying strengths. Lawyers and defendants must therefore continue evaluating claims individually even after significant common issues have been litigated.
Causation Often Shapes Settlement as Much as Trial Strategy
Individual causation also has considerable significance outside the courtroom. Large-scale settlements are not always structured as identical payments to every claimant. Instead, settlement frameworks may divide plaintiffs into categories according to factors such as the nature of the injury, duration of exposure, age, medical history, severity of harm, supporting documentation, and other criteria relevant to the strength or value of the claim.
Causation evidence can therefore affect whether a plaintiff qualifies for compensation under a settlement program and, if so, how a claim is evaluated within that structure.
This creates a practical reason for detailed case development even when attorneys believe the litigation is ultimately likely to settle. Gathering medical records, establishing product identification, documenting exposure, reviewing competing risk factors, and obtaining appropriate expert analysis should not be viewed solely as preparation for trial. Those same materials may determine how a claimant is positioned during settlement negotiations.
There is also an important screening function at the beginning of litigation. Publicity surrounding major lawsuits can sometimes create the impression that anyone who used a particular product and subsequently developed a certain condition has a viable legal claim. The reality is more demanding. Attorneys must consider whether the scientific evidence supports the alleged relationship, whether exposure can be demonstrated, whether the medical chronology makes sense, whether other causes materially weaken the claim, and whether procedural requirements such as limitation periods have been satisfied.
That process protects the integrity of the litigation as a whole. A mass tort proceeding may involve allegations common to thousands of people, but its credibility ultimately depends on the ability to establish genuine individual injuries and genuine causal connections.
The Individual Claim Remains at the Center
Mass tort litigation achieves scale by coordinating common issues, not by eliminating individuality. Shared discovery, expert testimony, corporate evidence, and pretrial rulings can make extraordinarily complex litigation more manageable, but they cannot substitute for proof connecting the defendant’s conduct to the plaintiff standing behind each claim.
That distinction has consequences at every stage of a case. It influences initial screening, discovery strategy, expert testimony, bellwether selection, settlement valuation, and ultimately the question of whether a plaintiff can satisfy the applicable burden of proof.
The largest mass tort proceedings may contain thousands of files and involve nationwide litigation strategies, but each file represents a separate factual inquiry. Understanding that reality is essential to understanding mass tort law itself: the litigation may be collective in scale, but causation remains fundamentally individual.
